{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:28:14Z","timestamp":1793104094006,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100019492","name":"National Natural Science Foundation of China-China Academy of General Technology Joint Fund for Basic Research","doi-asserted-by":"publisher","award":["82072550"],"award-info":[{"award-number":["82072550"]}],"id":[{"id":"10.13039\/501100019492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04761-0","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T15:54:50Z","timestamp":1762962890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["iPSCs derived sEVs ameliorate NK cell senescence by targeting CISH-STAT3"],"prefix":"10.1186","volume":"16","author":[{"given":"Yu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengsheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juntao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8238-7988","authenticated-orcid":false,"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"issue":"35","key":"4761_CR1","doi-asserted-by":"publisher","first-page":"eabn6240","DOI":"10.1126\/sciadv.abn6240","volume":"8","author":"M Son","year":"2022","unstructured":"Son M, Frank T, Holst-Hansen T, et al. Spatiotemporal NF-kappaB dynamics encodes the position, amplitude, and duration of local immune inputs. Sci Adv. 2022;8(35):eabn6240.","journal-title":"Sci Adv"},{"issue":"1","key":"4761_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41392-023-01451-2","volume":"8","author":"Z Liu","year":"2023","unstructured":"Liu Z, Liang Q, Ren Y, et al. Immunosenescence: molecular mechanisms and diseases. Signal Transduct Target Therapy. 2023;8(1):200.","journal-title":"Signal Transduct Target Therapy"},{"key":"4761_CR3","doi-asserted-by":"publisher","first-page":"942796","DOI":"10.3389\/fimmu.2022.942796","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Dong C, Han Y, Gu Z, Sun C. Immunosenescence, aging and successful aging. Front Immunol. 2022;13:942796.","journal-title":"Front Immunol"},{"issue":"1","key":"4761_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13045-020-00986-z","volume":"13","author":"J Lian","year":"2020","unstructured":"Lian J, Yue Y, Yu W, Zhang Y. Immunosenescence: a key player in cancer development. J Hematol Oncol. 2020;13(1):151.","journal-title":"J Hematol Oncol"},{"key":"4761_CR5","doi-asserted-by":"crossref","unstructured":"Dallan B, Proietto D, De Laurentis M, et al. Age differentially impacts adaptive immune responses induced by adenoviral versus mRNA vaccines against COVID-19. Nat Aging. 2024.","DOI":"10.1038\/s43587-024-00644-w"},{"key":"4761_CR6","doi-asserted-by":"crossref","unstructured":"Teissier T, Boulanger E, Cox LS. Interconnections between inflammageing and Immunosenescence during ageing. Cells. 2022;11(3).","DOI":"10.3390\/cells11030359"},{"key":"4761_CR7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.0105-2896.2005.00260.x","volume":"205","author":"RD Stout","year":"2005","unstructured":"Stout RD, Suttles J. Immunosenescence and macrophage functional plasticity: dysregulation of macrophage function by age-associated microenvironmental changes. Immunol Rev. 2005;205:60\u201371.","journal-title":"Immunol Rev"},{"key":"4761_CR8","doi-asserted-by":"crossref","unstructured":"Chu JF, Gao FC, Yan MM, et al. Natural killer cells: a promising immunotherapy for cancer. J Transl Med. 2022;20(1).","DOI":"10.1186\/s12967-022-03437-0"},{"key":"4761_CR9","doi-asserted-by":"crossref","unstructured":"Chan IS, Ewald AJ. The changing role of natural killer cells in cancer metastasis. J Clin Invest. 2022;132(6).","DOI":"10.1172\/JCI143762"},{"key":"4761_CR10","doi-asserted-by":"crossref","unstructured":"Qi CY, Liu Q. Natural killer cells in aging and age-related diseases. Neurobiol Dis. 2023;183.","DOI":"10.1016\/j.nbd.2023.106156"},{"key":"4761_CR11","doi-asserted-by":"crossref","unstructured":"Du N, Guo F, Wang Y, Cui J. NK cell therapy: a rising star in cancer treatment. Cancers (Basel). 2021;13(16).","DOI":"10.3390\/cancers13164129"},{"key":"4761_CR12","doi-asserted-by":"crossref","unstructured":"Ram\u00edrez-Labrada A, Pesini C, Santiago L, et al. All about (NK cell-mediated) death in two acts and an unexpected encore: Initiation, execution and activation of adaptive immunity. Front Immunol. 2022;13.","DOI":"10.3389\/fimmu.2022.896228"},{"key":"4761_CR13","doi-asserted-by":"crossref","unstructured":"Corvino D, Kumar A, Bald T. Plasticity of NK cells in cancer. Front Immunol 2022;13.","DOI":"10.3389\/fimmu.2022.888313"},{"issue":"4","key":"4761_CR14","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00262-015-1750-0","volume":"65","author":"AR Manser","year":"2016","unstructured":"Manser AR, Uhrberg M. Age-related changes in natural killer cell repertoires: impact on NK cell function and immune surveillance. Cancer Immunol Immunother. 2016;65(4):417\u201326.","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"4761_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00262-016-1882-x","volume":"66","author":"R Tarazona","year":"2017","unstructured":"Tarazona R, Sanchez-Correa B, Casas-Avil\u00e9s I, et al. Immunosenescence: limitations of natural killer cell-based cancer immunotherapy. Cancer Immunol Immun. 2017;66(2):233\u201345.","journal-title":"Cancer Immunol Immun"},{"key":"4761_CR16","doi-asserted-by":"crossref","unstructured":"Lian JY, Yue Y, Yu WN, Zhang Y. Immunosenescence: a key player in cancer development. J Hematol Oncol. 2020;13(1).","DOI":"10.1186\/s13045-020-00986-z"},{"key":"4761_CR17","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.3389\/fimmu.2019.01703","volume":"10","author":"WY Moon","year":"2019","unstructured":"Moon WY, Powis SJ. Does natural killer cell deficiency (NKD) increase the risk of cancer? NKD May increase the risk of some virus induced cancer. Front Immunol. 2019;10:1703.","journal-title":"Front Immunol"},{"key":"4761_CR18","doi-asserted-by":"crossref","unstructured":"Brauning A, Rae M, Zhu G, et al. Aging of the immune system: focus on natural killer cells phenotype and functions. Cells. 2022;11(6).","DOI":"10.3390\/cells11061017"},{"issue":"5","key":"4761_CR19","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/j.1474-9726.2012.00839.x","volume":"11","author":"J Hazeldine","year":"2012","unstructured":"Hazeldine J, Hampson P, Lord JM. Reduced release and binding of Perforin at the immunological synapse underlies the age-related decline in natural killer cell cytotoxicity. Aging Cell. 2012;11(5):751\u20139.","journal-title":"Aging Cell"},{"key":"4761_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mad.2013.11.007","volume":"135","author":"E Beli","year":"2014","unstructured":"Beli E, Duriancik DM, Clinthorne JF, Lee T, Kim S, Gardner EM. Natural killer cell development and maturation in aged mice. Mech Ageing Dev. 2014;135:33\u201340.","journal-title":"Mech Ageing Dev"},{"issue":"4","key":"4761_CR21","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.arr.2013.04.003","volume":"12","author":"J Hazeldine","year":"2013","unstructured":"Hazeldine J, Lord JM. The impact of ageing on natural killer cell function and potential consequences for health in older adults. Ageing Res Rev. 2013;12(4):1069\u201378.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"4761_CR22","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1186\/s13287-020-01993-0","volume":"11","author":"Y Xiong","year":"2020","unstructured":"Xiong Y, Wang Y, Zhang J, et al. hPMSCs protects against D-galactose-induced oxidative damage of CD4(+) T cells through activating Akt-mediated Nrf2 antioxidant signaling. Stem Cell Res Ther. 2020;11(1):468.","journal-title":"Stem Cell Res Ther"},{"key":"4761_CR23","doi-asserted-by":"crossref","unstructured":"Gong LZ, Chen B, Zhang JT, et al. Human ESC-sEVs alleviate age-related bone loss by rejuvenating senescent bone marrow-derived mesenchymal stem cells. J Extracell Vesicles. 2020;9(1).","DOI":"10.1080\/20013078.2020.1800971"},{"issue":"6","key":"4761_CR24","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/stem.2996","volume":"37","author":"S Liu","year":"2019","unstructured":"Liu S, Mahairaki V, Bai H, et al. Highly purified human extracellular vesicles produced by stem cells alleviate aging cellular phenotypes of senescent human cells. Stem Cells. 2019;37(6):779\u201390.","journal-title":"Stem Cells"},{"issue":"1","key":"4761_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ymthe.2020.09.037","volume":"29","author":"G Hu","year":"2021","unstructured":"Hu G, Xia Y, Chen B, et al. ESC-sEVs rejuvenate aging hippocampal NSCs by transferring SMADs to regulate the MYT1-Egln3-Sirt1 axis. Mol Ther. 2021;29(1):103\u201320.","journal-title":"Mol Ther"},{"key":"4761_CR26","doi-asserted-by":"crossref","unstructured":"Hu GW, Xia YG, Zhang JT, et al. ESC-sEVs rejuvenate senescent hippocampal NSCs by activating lysosomes to improve cognitive dysfunction in vascular dementia. Adv Sci. 2020;7(10).","DOI":"10.1002\/advs.201903330"},{"key":"4761_CR27","doi-asserted-by":"publisher","first-page":"100600","DOI":"10.1016\/j.mtbio.2023.100600","volume":"19","author":"X Niu","year":"2023","unstructured":"Niu X, Xia Y, Luo L, et al. iPSC-sEVs alleviate microglia senescence to protect against ischemic stroke in aged mice. Mater Today Bio. 2023;19:100600.","journal-title":"Mater Today Bio"},{"issue":"2","key":"4761_CR28","doi-asserted-by":"publisher","first-page":"e12409","DOI":"10.1002\/jev2.12409","volume":"13","author":"Z Chen","year":"2024","unstructured":"Chen Z, Luo L, Ye T, et al. Identification of specific markers for human pluripotent stem cell-derived small extracellular vesicles. J Extracell Vesicles. 2024;13(2):e12409.","journal-title":"J Extracell Vesicles"},{"issue":"2","key":"4761_CR29","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41590-024-02059-6","volume":"26","author":"Y Wang","year":"2025","unstructured":"Wang Y, Li R, Tong R, et al. Integrating single-cell RNA and T cell\/B cell receptor sequencing with mass cytometry reveals dynamic trajectories of human peripheral immune cells from birth to old age. Nat Immunol. 2025;26(2):308\u201322.","journal-title":"Nat Immunol"},{"key":"4761_CR30","doi-asserted-by":"publisher","first-page":"4574276","DOI":"10.1155\/2019\/4574276","volume":"2019","author":"I Martinez de Toda","year":"2019","unstructured":"Martinez de Toda I, Vida C, Sanz San Miguel L, De la Fuente M, Function. Oxidative, and inflammatory stress parameters in immune cells as predictive markers of lifespan throughout aging. Oxid Med Cell Longev. 2019;2019:4574276.","journal-title":"Oxid Med Cell Longev"},{"key":"4761_CR31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.mad.2019.01.006","volume":"178","author":"P Rosenstock","year":"2019","unstructured":"Rosenstock P, Bezold V, Bork K, Scheffler J, Horstkorte R. Glycation interferes with natural killer cell function. Mech Ageing Dev. 2019;178:64\u201371.","journal-title":"Mech Ageing Dev"},{"issue":"7667","key":"4761_CR32","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature23450","volume":"548","author":"HB Li","year":"2017","unstructured":"Li HB, Tong J, Zhu S, et al. m(6)A mRNA methylation controls T cell homeostasis by targeting the IL-7\/STAT5\/SOCS pathways. Nature. 2017;548(7667):338\u201342.","journal-title":"Nature"},{"issue":"7","key":"4761_CR33","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1111\/cas.15824","volume":"114","author":"T Kakuda","year":"2023","unstructured":"Kakuda T, Suzuki J, Matsuoka Y, Kikugawa T, Saika T, Yamashita M. Senescent CD8(+) T cells acquire NK cell-like innate functions to promote antitumor immunity. Cancer Sci. 2023;114(7):2810\u201320.","journal-title":"Cancer Sci"},{"issue":"1","key":"4761_CR34","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12967-022-03437-0","volume":"20","author":"J Chu","year":"2022","unstructured":"Chu J, Gao F, Yan M, et al. Natural killer cells: a promising immunotherapy for cancer. J Transl Med. 2022;20(1):240.","journal-title":"J Transl Med"},{"issue":"1","key":"4761_CR35","doi-asserted-by":"publisher","first-page":"4746","DOI":"10.1038\/s41467-021-25009-4","volume":"12","author":"EV Petley","year":"2021","unstructured":"Petley EV, Koay HF, Henderson MA, et al. MAIT cells regulate NK cell-mediated tumor immunity. Nat Commun. 2021;12(1):4746.","journal-title":"Nat Commun"},{"issue":"6","key":"4761_CR36","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1073\/pnas.050588297","volume":"97","author":"S Kim","year":"2000","unstructured":"Kim S, Iizuka K, Aguila HL, Weissman IL, Yokoyama WM. In vivo natural killer cell activities revealed by natural killer cell-deficient mice. Proc Natl Acad Sci U S A. 2000;97(6):2731\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4761_CR37","first-page":"63","volume":"31","author":"H Zhang","year":"2024","unstructured":"Zhang H, Yang L, Wang T, Li Z. NK cell-based tumor immunotherapy. Bioact Mater. 2024;31:63\u201386.","journal-title":"Bioact Mater"},{"issue":"5","key":"4761_CR38","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s43587-022-00231-x","volume":"2","author":"The importance of","year":"2022","unstructured":"The importance of. Aging in cancer research. Nat Aging. 2022;2(5):365\u20136.","journal-title":"Nat Aging"},{"issue":"7","key":"4761_CR39","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/s41416-019-0721-1","volume":"122","author":"E Laconi","year":"2020","unstructured":"Laconi E, Marongiu F, DeGregori J. Cancer as a disease of old age: changing mutational and microenvironmental landscapes. Br J Cancer. 2020;122(7):943\u201352.","journal-title":"Br J Cancer"},{"issue":"9","key":"4761_CR40","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1080\/14737140.2022.2098718","volume":"22","author":"JE Rodriguez","year":"2022","unstructured":"Rodriguez JE, Naigeon M, Goldschmidt V, et al. Immunosenescence, inflammaging, and cancer immunotherapy efficacy. Expert Rev Anticanc. 2022;22(9):915\u201326.","journal-title":"Expert Rev Anticanc"},{"issue":"7","key":"4761_CR41","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.4049\/jimmunol.1600590","volume":"197","author":"B Muller-Durovic","year":"2016","unstructured":"Muller-Durovic B, Lanna A, Covre LP, Mills RS, Henson SM, Akbar AN. Killer cell Lectin-like receptor G1 inhibits NK cell function through activation of adenosine 5\u2019-Monophosphate-Activated protein kinase. J Immunol. 2016;197(7):2891\u20139.","journal-title":"J Immunol"},{"issue":"7","key":"4761_CR42","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.humimm.2010.03.014","volume":"71","author":"RP Hayhoe","year":"2010","unstructured":"Hayhoe RP, Henson SM, Akbar AN, Palmer DB. Variation of human natural killer cell phenotypes with age: identification of a unique KLRG1-negative subset. Hum Immunol. 2010;71(7):676\u201381.","journal-title":"Hum Immunol"},{"issue":"4","key":"4761_CR43","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/JLB.4MR0620-091R","volume":"108","author":"AM Merino","year":"2020","unstructured":"Merino AM, Kim H, Miller JS, Cichocki F. Unraveling exhaustion in adaptive and conventional NK cells. J Leukoc Biol. 2020;108(4):1361\u20138.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"4761_CR44","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41392-024-01809-0","volume":"9","author":"J Cerneckis","year":"2024","unstructured":"Cerneckis J, Cai H, Shi Y. Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications. Signal Transduct Target Therapy. 2024;9(1):112.","journal-title":"Signal Transduct Target Therapy"},{"issue":"7","key":"4761_CR45","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41576-019-0100-z","volume":"20","author":"RG Rowe","year":"2019","unstructured":"Rowe RG, Daley GQ. Induced pluripotent stem cells in disease modelling and drug discovery. Nat Rev Genet. 2019;20(7):377\u201388.","journal-title":"Nat Rev Genet"},{"key":"4761_CR46","first-page":"85","volume":"29","author":"L Yu","year":"2023","unstructured":"Yu L, Wen H, Liu C, et al. Embryonic stem cell-derived extracellular vesicles rejuvenate senescent cells and antagonize aging in mice. Bioact Mater. 2023;29:85\u201397.","journal-title":"Bioact Mater"},{"issue":"1","key":"4761_CR47","doi-asserted-by":"publisher","first-page":"1800971","DOI":"10.1080\/20013078.2020.1800971","volume":"9","author":"L Gong","year":"2020","unstructured":"Gong L, Chen B, Zhang J, et al. Human ESC-sEVs alleviate age-related bone loss by rejuvenating senescent bone marrow-derived mesenchymal stem cells. J Extracell Vesicles. 2020;9(1):1800971.","journal-title":"J Extracell Vesicles"},{"key":"4761_CR48","doi-asserted-by":"publisher","first-page":"102391","DOI":"10.1016\/j.arr.2024.102391","volume":"99","author":"E Rudnitsky","year":"2024","unstructured":"Rudnitsky E, Braiman A, Wolfson M, et al. Stem cell-derived extracellular vesicles as senotherapeutics. Ageing Res Rev. 2024;99:102391.","journal-title":"Ageing Res Rev"},{"issue":"12","key":"4761_CR49","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1002\/j.1460-2075.1995.tb07281.x","volume":"14","author":"A Yoshimura","year":"1995","unstructured":"Yoshimura A, Ohkubo T, Kiguchi T, et al. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated Interleukin 3 and erythropoietin receptors. EMBO J. 1995;14(12):2816\u201326.","journal-title":"EMBO J"},{"issue":"2","key":"4761_CR50","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.stem.2020.05.008","volume":"27","author":"H Zhu","year":"2020","unstructured":"Zhu H, Blum RH, Bernareggi D, et al. Metabolic reprograming via deletion of CISH in human iPSC-Derived NK cells promotes in vivo persistence and enhances Anti-tumor activity. Cell Stem Cell. 2020;27(2):224\u2013e237226.","journal-title":"Cell Stem Cell"},{"issue":"7","key":"4761_CR51","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ni.3470","volume":"17","author":"RB Delconte","year":"2016","unstructured":"Delconte RB, Kolesnik TB, Dagley LF, et al. CIS is a potent checkpoint in NK cell-mediated tumor immunity. Nat Immunol. 2016;17(7):816\u201324.","journal-title":"Nat Immunol"},{"key":"4761_CR52","doi-asserted-by":"crossref","unstructured":"Bernard PL, Delconte R, Pastor S, et al. Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity. J Immunother Cancer. 2022;10(5).","DOI":"10.1136\/jitc-2021-004244"},{"key":"4761_CR53","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.3389\/fimmu.2019.02087","volume":"10","author":"SE Clark","year":"2019","unstructured":"Clark SE, Burrack KS, Jameson SC, Hamilton SE, Lenz LL. NK cell IL-10 production requires IL-15 and IL-10 driven STAT3 activation. Front Immunol. 2019;10:2087.","journal-title":"Front Immunol"},{"key":"4761_CR54","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3389\/fimmu.2016.00128","volume":"7","author":"NA Cacalano","year":"2016","unstructured":"Cacalano NA. Regulation of natural killer cell function by STAT3. Front Immunol. 2016;7:128.","journal-title":"Front Immunol"},{"issue":"8","key":"4761_CR55","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1093\/ecco-jcc\/jjad041","volume":"17","author":"XM Hu","year":"2023","unstructured":"Hu XM, Jiao FX, Deng JL, et al. Intestinal epithelial Cell-specific deletion of Cytokine-inducible SH2-containing protein alleviates experimental colitis in ageing mice (Mar, jjad041, 2023). J Crohns Colitis. 2023;17(8):1369\u20131369.","journal-title":"J Crohns Colitis"},{"issue":"5","key":"4761_CR56","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s43587-023-00399-w","volume":"3","author":"J Jin","year":"2023","unstructured":"Jin J, Mu Y, Zhang H, et al. CISH impairs lysosomal function in activated T cells resulting in mitochondrial DNA release and inflammaging. Nat Aging. 2023;3(5):600\u201316.","journal-title":"Nat Aging"},{"issue":"5\u20136","key":"4761_CR57","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.cytogfr.2008.08.006","volume":"19","author":"J Piessevaux","year":"2008","unstructured":"Piessevaux J, Lavens D, Peelman F, Tavernier J. The many faces of the SOCS box. Cytokine Growth Factor Rev. 2008;19(5\u20136):371\u201381.","journal-title":"Cytokine Growth Factor Rev"},{"key":"4761_CR58","doi-asserted-by":"publisher","first-page":"836724","DOI":"10.3389\/fphar.2022.836724","volume":"13","author":"Y Hua","year":"2022","unstructured":"Hua Y, Yuan X, Shen YH, et al. Novel STAT3 inhibitors targeting STAT3 dimerization by binding to the STAT3 SH2 domain. Front Pharmacol. 2022;13:836724.","journal-title":"Front Pharmacol"},{"key":"4761_CR59","doi-asserted-by":"publisher","first-page":"1271102","DOI":"10.3389\/fimmu.2023.1271102","volume":"14","author":"R Pandey","year":"2023","unstructured":"Pandey R, Bakay M, Hakonarson H. SOCS-JAK-STAT inhibitors and SOCS mimetics as treatment options for autoimmune uveitis, psoriasis, lupus, and autoimmune encephalitis. Front Immunol. 2023;14:1271102.","journal-title":"Front Immunol"},{"key":"4761_CR60","doi-asserted-by":"publisher","first-page":"1265818","DOI":"10.3389\/fimmu.2023.1265818","volume":"14","author":"W Wang","year":"2023","unstructured":"Wang W, Lopez McDonald MC, Kim C, et al. The complementary roles of STAT3 and STAT1 in cancer biology: insights into tumor pathogenesis and therapeutic strategies. Front Immunol. 2023;14:1265818.","journal-title":"Front Immunol"},{"key":"4761_CR61","doi-asserted-by":"crossref","unstructured":"Maymand S, Lakkavaram AL, Naser W, et al. Role of cytokine-inducible SH2 domain-containing (CISH) protein in the regulation of erythropoiesis. Biomolecules. 2023;13(10).","DOI":"10.3390\/biom13101510"},{"key":"4761_CR62","doi-asserted-by":"publisher","first-page":"1449397","DOI":"10.3389\/fimmu.2024.1449397","volume":"15","author":"DM Lynch","year":"2024","unstructured":"Lynch DM, Forrester B, Webb T, Ciulli A. Unravelling the druggability and immunological roles of the SOCS-family proteins. Front Immunol. 2024;15:1449397.","journal-title":"Front Immunol"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04761-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04761-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04761-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T17:03:05Z","timestamp":1762966985000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04761-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4761"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04761-0","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"16 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"iPSC-sEVs were obtained from the serum-free supernatant of Human iPSC Line nciPS01(RC01001-A, Male, Shownin Biotechnologies Co., Ltd). K562 was purchased from the Cell Bank of the Chinese Academy of Sciences. NK92 was purchased from Whelab Cell Bank. All cell lines were obtained with documented ethical compliance, including institutional ethics approval and donor informed consent. The animal care and experimental procedures were approved by the Animal Research Committee of the Shanghai Jiao Tong University Affiliated Sixth People\u2019s Hospital (Title: Research on the Mechanism of Stem Cell derived EVs in Regulating and Preventing Age-related Degenerative Diseases; Diseases; Approval Number: DWSY2022-0165; Date of approval: 22\/01\/2022). This study is part of the research on improving age-related diseases by stem cell-derived EVs, and was conformed to the Guide for the Care and Use of Laboratory Animal published by the US National Institutes of Health (NIH publication, 8th edition, 2011). Our experiment complied with the regulations of the guidelines for tumor research (NIH, Guidelines for Endpoints in Animal Study Proposals (2019).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors have approved the manuscript and agree with its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"634"}}